Molecule Holdings Inc.
EVRRF · OTC
7/31/2023 | 4/30/2023 | 1/31/2023 | 10/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 328% | -57.4% | -22.7% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 35% | 1.4% | -34.5% | -111.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -32% | -208.8% | -136.5% | -226.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -110.2% | -527.8% | -174.9% | -291% |
| EPS Diluted | -0.008 | -0.009 | -0.007 | -0.015 |
| % Growth | 11.1% | -28.6% | 53.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |